Jerusalem Pharmaceuticals Market Cap

Jerusalem Pharmaceuticals has a market cap or net worth of 52.94 million as of August 14, 2025. Its market cap has increased by 31.64% in one year.

Market Cap

52.94M

Enterprise Value

44.13M

Revenue

31.34M

Ranking

n/a

PE Ratio

9.66

Stock Price

4.15

Market Cap Chart

Since December 15, 2008, Jerusalem Pharmaceuticals's market cap has increased from 14.89M to 52.94M, an increase of 255.59%. That is a compound annual growth rate of 7.91%.

Market Cap History

Date	Market Cap	% Change
Aug 14, 2025	52.94M	8.16%
Dec 24, 2024	48.95M	0.78%
Dec 31, 2023	48.57M	15.89%
Dec 29, 2022	41.91M	16.10%
Dec 23, 2021	36.10M	2.12%
Dec 31, 2020	35.35M	-1.04%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Palestine Telecommunications Company P.L.C	631.80M
Bank of Palestine	300.99M
Palestine Development & Investment Co.	254.86M
Arab Palestinian Investment Company	206.34M
Wataniya Palestine Mobile Telecommunication - Public Shareholding Company	191.01M
Arkaan Real Estate P.L.C	177.25M
The National Bank	113.83M
Birzeit Pharmaceuticals Company	105.50M

Market Cap Rankings